| WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) inhibits GLUT1-mediated sugar transport by binding reversibly at the exofacial sugar binding site OA Ojelabi, KP Lloyd, AH Simon, JK De Zutter, A Carruthers Journal of Biological Chemistry 291 (52), 26762-26772, 2016 | 97 | 2016 |
| Nanomolar potency and selectivity of a Ca2+ release‐activated Ca2+ channel inhibitor against store‐operated Ca2+ entry and migration of vascular smooth … J Li, L McKeown, O Ojelabi, M Stacey, R Foster, D O'Regan, KE Porter, ... British journal of pharmacology 164 (2), 382-393, 2011 | 75 | 2011 |
| Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease AC Adejumo, TO Ajayi, OM Adegbala, KL Adejumo, S Alliu, AM Akinjero, ... Liver International 38 (8), 1475-1486, 2018 | 49 | 2018 |
| UPF1 is crucial for the infectivity of human immunodeficiency virus type 1 progeny virions AKP Serquiña, SR Das, E Popova, OA Ojelabi, CK Roy, HG Göttlinger Journal of virology 87 (16), 8853-8861, 2013 | 46 | 2013 |
| LHRH-conjugated drugs as targeted therapeutic agents for the specific targeting and localized treatment of triple negative breast cancer JD Obayemi, AA Salifu, SC Eluu, VO Uzonwanne, SM Jusu, CC Nwazojie, ... Scientific Reports 10 (1), 8212, 2020 | 34 | 2020 |
| Red wine and green tea flavonoids are cis-allosteric activators and competitive inhibitors of glucose transporter 1 (GLUT1)-mediated sugar uptake OA Ojelabi, KP Lloyd, JK De Zutter, A Carruthers Journal of Biological Chemistry 293 (51), 19823-19834, 2018 | 34 | 2018 |
| Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector H Zhang, N Bamidele, P Liu, O Ojelabi, XD Gao, T Rodriguez, H Cheng, ... GEN biotechnology 1 (3), 285-299, 2022 | 30 | 2022 |
| Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States AC Adejumo, GO Samuel, OM Adegbala, KL Adejumo, O Ojelabi, ... Annals of gastroenterology 32 (5), 504, 2019 | 27 | 2019 |
| Reconciling contradictory findings: Glucose transporter 1 (GLUT1) functions as an oligomer of allosteric, alternating access transporters KP Lloyd, OA Ojelabi, JK De Zutter, A Carruthers Journal of Biological Chemistry 292 (51), 21035-21046, 2017 | 26 | 2017 |
| Orthogonal CRISPR-Cas tools for genome editing, inhibition, and CRISPR recording in zebrafish embryos PR Takasugi, S Wang, KT Truong, EP Drage, SN Kanishka, MA Higbee, ... Genetics 220 (1), iyab196, 2022 | 12 | 2022 |
| Novel small molecule, WZB117, competitively inhibit GLUT1‐mediated glucose transport to halt cancer growth O Ojelabi, J DeZutter, K Lloyd, A Carruthers The FASEB Journal 30, 1099.1-1099.1, 2016 | 9 | 2016 |
| Kinetic Basis of Cis- and Trans-Allostery in GLUT1-Mediated Sugar Transport KP Lloyd, OA Ojelabi, AH Simon, JK De Zutter, A Carruthers The Journal of membrane biology 251, 131-152, 2018 | 6 | 2018 |
| Itaconate impairs immune control of Plasmodium by enhancing mtDNA-mediated PD-L1 expression in monocyte-derived dendritic cells T Ramalho, PA Assis, O Ojelabi, L Tan, B Carvalho, L Gardinassi, ... Cell Metabolism, 2024 | 4 | 2024 |
| Small molecule modulation of GLUT1-mediated glucose transport OA Ojelabi | 3 | 2017 |
| Orthogonal CRISPR-Cas genome editing and efficient inhibition with anti-CRISPRs in zebrafish embryos P Takasugi, EP Drage, SN Kanishka bioRxiv, 1-9, 2020 | 1 | 2020 |
| Acute Stimulation of GLUT1 Cell Surface Localization in Blood‐Brain Barrier Endothelial Cells O Ojelabi, A Carruthers The FASEB Journal 29, 574.13, 2015 | 1 | 2015 |
| Reprogramming of host energy metabolism mediated by the TNF-iNOS-HIF-1alpha axis plays a key role in host resistance to Plasmodium infection KC Matteucci, PA Assis, IC Hirako, NPS Leite, F Pioto, O Ojelabi, ... bioRxiv, 2024.03. 26.586751, 2024 | | 2024 |
| Let us know how access to this document benefits you. A Adejumo, GO Samuel, OM Adegbala, KL Adejumo, O Ojelabi, O Akanbi, ... Prevalence 2019, 09-01, 2019 | | 2019 |
| Let us know how access to this document benefits you. OA Ojelabi Small 2017, 12-21, 2017 | | 2017 |
| Frequent Cannabis Users Have Reduced Odds for Non Alcoholic Fatty Liver Disease A Adejumo, N Onyeakusi, S Alliu, OA Ojelabi | | 2017 |
